Pier Capital, LLC Iveric Bio, Inc. Transaction History

Pier Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$18.67 - $24.56 $44,994 - $59,189	2,410 Added 1.05%	231,162 $5.62 Million
Q4 2022 Feb 15, 2023	SELL	$17.24 - $23.95 $55,685 - $77,358	-3,230 Reduced 1.39%	228,752 $4.9 Million
Q3 2022 Nov 15, 2022	SELL	$9.4 - $18.59 $1.04 Million - $2.06 Million	-110,905 Reduced 32.34%	231,982 $4.16 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $1.95 Million - $4.04 Million	-213,954 Reduced 38.42%	342,887 $3.3 Million
Q1 2022 May 10, 2022	BUY	$12.15 - $16.83 $1.56 Million - $2.16 Million	128,387 Added 29.97%	556,841 $9.37 Million
Q4 2021 Feb 10, 2022	BUY	$13.83 - $18.78 $5.93 Million - $8.05 Million	428,454 New	428,454 $7.16 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.